Research progress in downstaging treatment of hepatocellular carcinoma before liver transplantation / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
; (12): 305-309, 2021.
Article
en Zh
| WPRIM
| ID: wpr-884659
Biblioteca responsable:
WPRO
ABSTRACT
Liver transplantation is an effective curative treatment for hepatocellular carcinoma patients. However, most patients lost the change of surgery when diagnosed as hepatocellular carcinoma. Through local or systemic treatment, hepatocellular carcinoma can be treated in a downstaging manner to reduce tumor burden, so that patients who are beyond the transplantation criteria can still be up to the transplantation criteria after treatment, and finally receive liver transplantation. At present, pre-transplant downstaging treatment has been widely accepted. In this review, we summarized the indications, treatment options, treatment endpoints, and treatment outcomes of pre-transplant downstaging treatment.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Hepatobiliary Surgery
Año:
2021
Tipo del documento:
Article